Dev Arya
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$7.5MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $7.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 19, 2021 | NIH | STTR Phase II Aminoglycosides with reduced ototoxicity | $2.0M | NUBAD LLC with CLEMSON UNIVERSITY |
| Feb 10, 2021 | NIH | STTR Phase II Development of peptide nucleic acid antibiotics | $2.0M | NUBAD LLC with CLEMSON UNIVERSITY |
| Mar 6, 2020 | NIH | STTR Phase I Delivery of chemically modified PNA oligomers | $804K | NUBAD LLC with CLEMSON UNIVERSITY |
| Mar 15, 2019 | NIH | STTR Phase I Aminoglycosides with reduced ototoxicity via miRNA targeting | $755K | NUBAD LLC with CLEMSON UNIVERSITY |
| Dec 1, 2017 | NIH | STTR Phase I Nucleobase aminosugars with reduced ototoxicity | $670K | NUBAD LLC with CLEMSON UNIVERSITY |
| Aug 1, 2016 | NIH | STTR Phase I Aminoglycosides with reduced ototoxicity | $600K | NUBAD LLC with CLEMSON UNIVERSITY |
| Jul 13, 2016 | NIH | STTR Phase I Screening the Ribosome for New Target Sites | $650K | NUBAD LLC with CLEMSON UNIVERSITY |
Peer ranks
Federal funding#128
Awards as PI#250
Patents#273
Companies
- NUBAD LLCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.